Xilio Therapeutics (XLO) Shares Outstanding (Entity) (2020 - 2026)
Xilio Therapeutics' Shares Outstanding (Entity) was 19.4 million in Q2 2026, up 181.7% from 6.89 million a year earlier and up 18.7% from the prior quarter.
Powered by 
Analysis
Xilio Therapeutics (XLO) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Xilio Therapeutics came in at 8.36 million, up 155.8% from FY2024.
- Shares Outstanding (Entity) has now increased for five consecutive years, with a five-year compound annual growth rate of 195.0% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 3.27 million in FY2024 (+65.7%), 1.97 million in FY2023 (+0.7%), 1.96 million in FY2022 (+389.2%) and 400,451 in FY2021 (+970.4%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2020.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for 15 straight quarters, with growth averaging 137.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.2% (Q1 2023) to 970.4% (Q4 2021).
- Per Business Quant data, XLO's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 16.35 million (Q1 2026), 8.36 million (Q4 2025) and 10.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Xilio Therapeutics | 162.81 Mn | -364.86 Mn | - | 19.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.40 Mn |
| Mar 31, 2026 | 16.35 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Jun 30, 2025 | 6.89 Mn |
| Mar 31, 2025 | 5.34 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 4.53 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 1.96 Mn |
| Dec 31, 2021 | 400,451.00 |
| Sep 30, 2021 | 54,562.00 |
API Access
Xilio Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();